Briony Claxton

Briony Claxton

Auto-generated profile, based on publicly available information

Briony Claxton

School of Biomedical Sciences, Queensland University of Technology, 37 Kent Street, Woollongabba, Brisbane, 4102, AUSTRALIA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2026 in Biofabrication
Verified
Journal Article
Open access
SBSugandha Bhatia
Sugandha Bhatia
BCBriony Claxton
Briony Claxton
ETErik Walter Thompson
Erik Walter Thompson
MLMartin Lowe
Martin Lowe
MWMichael Wagels
Michael Wagels
JMJacqui McGovern
Jacqui McGovern
Osteosarcoma (OS) is the most common primary bone malignancy affecting children and adolescents, for which survival has not improved in more than four decades. The lack of accurate OS preclinical models hinders the understanding of tumor heterogeneity and its interaction with the surrounding extracellular matrix (ECM), limiting the discovery of predictive biomarkers and the development of effective therapies. Four 2D preclinical models from OS patients were established and characterized for their functional differences in comparison to OS cell lines for their growth, cellular phenotypic attributes, osteogenic differentiation capabilities and metabolic responses to growth factors and BMP-2. Molecular and cellular profiling revealed intra-tumoral heterogeneities that were very distinct from the endorsed OS cell lines. The OS patient-derived (PD) cells also displayed differential sensitivity to Doxorubicin and Cisplatin and resistance against Methotrexate. Subsequently, the 3D PDTs (Patient- derived tumoroids) models were developed by self-aggregating spheroids with and without Matrigel® ECM matrix. These PDTs models were screened for selective ECM and bone-specific gene markers, revealing dynamic differences between 2D and 3D models with and without ECM, with heightened dysregulation observed in 3D systems. The drug response variances observed among 2D OS cells and 3D tumoroids model within Matrigel® highlights the need for optimized platforms for in vitro personalized drug screening. Thus, our findings support the screening of preclinical PD OS models for phenotypic profiling and elucidating ECM contributions to drug responses and pathophysiology.

11 June 2025 in Acta Biomaterialia
Verified
Journal Article
Open access
SBSugandha Bhatia
Sugandha Bhatia
Luke James HipwoodLuke James Hipwood
Luke James Hipwood
BCBriony Claxton
Briony Claxton
ABAgathe Bessot
Agathe Bessot
Angus WeekesAngus Weekes
Angus Weekes
JMJacqui McGovern
Jacqui McGovern
Osteogenesis (bone formation) and vascularization (blood vessel formation) are two central and interconnected physiological-relevant processes in bone formation. Prevascularization of humanized tissue-engineered bone constructs (hTEBCs) has been proposed to better mimic the human bone microenvironment by enhancing vascular integration and facilitating greater osteogenic capacity. Here, we investigated the effects of premineralization and prevascularization on bone and vasculature development in an ectopic hTEBC model using a scaffold-hydrogel composite approach. Human osteoblast cells (hOBs) were cultured under osteogenic conditions (OM), with or without a 3-day mineralization boost (OM+) period for 4 weeks prior to implantation in vivo in a supporting porous polycaprolactone (mPCL) scaffold. Separately, photocrosslinkable fish gelatin-derived hydrogels placed within supporting mPCL scaffolds showed formation of elongated vascular networks as early as day 3 with in vitro coculture of human umbilical vein endothelial cells (HUVECs) and human bone marrow mesenchymal stem/stromal cells (MSCs). The OM and OM+ cultured constructs were subcutaneously implanted into immunocompromised rats with and without the prevascular hydrogels, resulting in four subgroups: OM, OM+, OM/Vas, and OM+/Vas. Our results demonstrated that the OM+ group led to more rapid osteoinduction and enhanced osteogenic differentiation in vivo with woven bone structure and active remodeling. Conversely, prevascularization (OM/Vas, OM+/Vas groups) led to reduce in vivo bone volume and density but promoted the development of human endothelial networks and successful anastomosis with host vasculature. Our study highlights the distinct contributions of premineralization and prevascularization, where premineralization is critical for robust bone formation and prevascularization enhances vascular integration, providing important insights for advancing the physiological relevance of hTEBC models in animal hosts. STATEMENT OF SIGNIFICANCE: This study demonstrates the development of humanized tissue engineered bone constructs incorporating a vascular niche using a rat. By integrating innovative pre-mineralization and pre-vascularization techniques within scaffold-hydrogel composite, we show that premineralization accelerates bone formation, while prevascularization promotes endothelial network formation and integration with host vasculature. Photocrosslinkable, low-stiffness LunaGel™ hydrogels enhanced microcapillary-like structure formation and endothelial sprouting in in vitro co-culture. However, by combining osteogenic and vascular cues within a biodegradable composite, this work advances the bone tissue engineering field by creating a model that more accurately reflects the divergent and competing nature of vascularization and bone formation. This platform has broad applicability for studying bone-vascular interactions and may inform strategies to improve the design of biomaterials for regenerative therapies.